Counteractive Effects of IL-33 and IL-37 on Inflammation in Osteoarthritis

Int J Environ Res Public Health. 2022 May 7;19(9):5690. doi: 10.3390/ijerph19095690.

Abstract

Osteoarthritis (OA) is a chronic inflammatory disease where pro-inflammatory cytokines, damage-associated molecular patterns (DAMPs), and macrophages play a crucial role. However, the interactive role of these mediators, the exact cause precipitating OA and definitive treatment for OA are not known yet. Moreover, the interactive role of interleukin (IL)-33 and IL-37 with other factors in the pathogenesis of OA has not been discussed elaborately. In this study, we analyzed the expression of IL-33 and IL-37 in human OA knee and hip joint cartilage tissues. The effect of increased DAMPs, IL-33, and IL-37 on IL-6, tumor necrosis factor (TNF)-α, toll-like receptors (TLRs), and matrix metalloproteinases (MMPs) expression was delineated using human normal and osteoarthritic chondrocytes. The effect of anti-inflammatory cytokine IL-37 on various mediators of inflammation in the presence of IL-33, rHMGB-1, and LPS was investigated to delineate the effects of IL-37. Further, the effects of blocking IL-33 downstream signaling and the effects of IL-33 and IL-37 on macrophage polarization were assessed along with examining the macrophage phenotypes in human OA cartilage tissues. The results of this study revealed increased expression of IL-33 in OA cartilage and that IL-33 increases IL-6, TNF-α, TLRs, and MMPs expression and favors phenotypic conversion towards the M1 phenotype, while IL-37 and blocking IL-33 receptor ST2 have opposite effects. Overall, the results suggest that blocking IL-33 and increasing IL-37 act synergistically to attenuate inflammation and might serve as potential therapeutics in OA.

Keywords: Interleukin-33; Interleukin-37; Macrophages; Toll-like receptors; damage-associated molecular patterns; inflammation; matrix metalloproteinases; osteoarthritis.

MeSH terms

  • Cartilage, Articular* / pathology
  • Cytokines / metabolism
  • Humans
  • Inflammation / pathology
  • Interleukin-1 / metabolism*
  • Interleukin-33 / metabolism*
  • Interleukin-6
  • Matrix Metalloproteinases / metabolism
  • Osteoarthritis* / pathology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cytokines
  • IL33 protein, human
  • IL37 protein, human
  • Interleukin-1
  • Interleukin-33
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Matrix Metalloproteinases